Applicability of Percutaneous Occlusion with Double Disc Prosthesis for Correction of Patent Foramen Ovale

• Published in: RGSA : Revista de Gestão Social e Ambiental Vol. 18; no. 1; p. e07736
• Main Authors: Nóbrega, Júlia Maria Minervino, Martins, Camila Cavalcante, Santos Neto, Célio Amorim dos, Souza, Eduardo Brasil de, Ribeiro Júnior, Francisco José Pascoal, Lucena, Hérika Juliana de Araújo, Cantuaria, Luma Rodrigues de Moura Peres, Schulz, Maria Eduarda Bonetti, Pereira, Marina Steingräber, Rodrigues, Miguel Valentim, Caldas, Silvia Letícia Cunha e Silva, Brandão, Thalyta Lopes, Pacheco, Thiago Jacobi
• Format: Journal Article
• Language: English
• Published: 25.06.2024
• ISSN: 1981-982X; 1981-982X
• DOI: 10.24857/rgsa.v18n1-171

Objective: To discuss the applicability of percutaneous occlusion with a double-disk prosthesis to correct patent foramen ovale.   Methodology: Integrative review of the literature carried out in the Virtual Health Library (VHL), Google Scholar and PubMed databases, using the Health Sciences (DeCS) descriptors: “Prosthesis design”, “Patent foramen ovale” and “Cardiac catheterization ” combined with each other by the Boolean operator AND.   Results: Patent foramen ovale (PFO) is a congenital condition characterized by non-healing of the foramen ovale after birth, which can lead to complications such as paradoxical embolism and cerebrovascular accidents. Percutaneous occlusion rates with double-disc prostheses have accompanied this increase in PFO detection, while the technique, which involves inserting a double-disc device into the foramen ovale to close it, has proven effective in preventing embolic events in patients with a history of cryptogenic stroke or other PFO-related manifestations. The approach of percutaneous occlusion with a double-disk prosthesis for PFO correction is, therefore, a valuable tool in the therapeutic arsenal to reduce the risk of embolic events in high-risk patients.   Conclusion: Percutaneous occlusion with a double disc prosthesis is an effective approach to preventing embolic events in patients with patent foramen ovale. Its growth reflects technological advances and understanding of the risks of FOP.